Select the Industry/ Sector šŸ‘‰    All Sectors

Top Healthcare Sector Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹4,700.6
₹56,202 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹25,744.3
₹54,705 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,135.8
₹26,893 Cr
Pharmaceuticals & Drugs
₹939.1
₹18,458 Cr
Pharmaceuticals & Drugs
₹520.0
₹4,713 Cr
Pharmaceuticals & Drugs
₹500.3
₹4,600 Cr
Pharmaceuticals & Drugs
₹386.2
₹4,318 Cr
Pharmaceuticals & Drugs
₹93.7
₹2,406 Cr
Pharmaceuticals & Drugs
₹1,196.1
₹683 Cr
Pharmaceuticals & Drugs
₹48.5
₹136 Cr

Top Healthcare Sector Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹4,700.6
₹12,634 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹939.1
₹6,118 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,135.8
₹4,036 Cr
Pharmaceuticals & Drugs
₹500.3
₹2,651 Cr
Pharmaceuticals & Drugs
₹520.0
₹1,832 Cr
Pharmaceuticals & Drugs
₹386.2
₹605 Cr
Pharmaceuticals & Drugs
₹93.7
₹146 Cr
Pharmaceuticals & Drugs
₹25,744.3
₹5,753 Cr
Pharmaceuticals & Drugs
₹1,196.1
₹355 Cr
Pharmaceuticals & Drugs
₹48.5
₹343 Cr

Top Healthcare Sector Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹4,700.6
₹1,575 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,135.8
₹736 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹939.1
₹599 Cr
Pharmaceuticals & Drugs
₹520.0
₹195 Cr
Pharmaceuticals & Drugs
₹500.3
₹180 Cr
Pharmaceuticals & Drugs
₹386.2
₹139 Cr
Pharmaceuticals & Drugs
₹93.7
₹76 Cr
Pharmaceuticals & Drugs
₹25,744.3
₹1,146 Cr
Pharmaceuticals & Drugs
₹1,196.1
₹66 Cr
Pharmaceuticals & Drugs
₹48.5
₹4 Cr

You may also like the below Video Courses